| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEODOLPASSE 0,30 mg+0,12 mg/ml | COMBINATII (DICLOFENACUM+ORPHENADRINUM CITRAS) | SOL. PERF. | M01AB55 | W64231001 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| NEODOLPASSE 0,30 mg+0,12 mg/ml | COMBINATII (DICLOFENACUM+ORPHENADRINUM CITRAS) | SOL. PERF. | M01AB55 | W64231002 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| NEODOLPASSE 0,30 mg+0,12 mg/ml | COMBINATII (DICLOFENACUM+ORPHENADRINUM CITRAS) | SOL. PERF. | M01AB55 | W64231003 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| NEOPHYR 1000 ppm mol/mol | AZOTUM OXIDUM | GAZ MEDICINAL COMPRIMAT | R07AX01 | W60118001 | SOL S.P.A. - ITALIA | ||||||
| NEOPHYR 1000 ppm mol/mol | AZOTUM OXIDUM | GAZ MEDICINAL COMPRIMAT | R07AX01 | W60118002 | SOL S.P.A. - ITALIA | ||||||
| NEOPHYR 225 ppm mol/mol | AZOTUM OXIDUM | GAZ MEDICINAL COMPRIMAT | R07AX01 | W60115001 | SOL S.P.A. - ITALIA | ||||||
| NEOPHYR 450 ppm mol/mol | AZOTUM OXIDUM | GAZ MEDICINAL COMPRIMAT | R07AX01 | W60117001 | SOL S.P.A. - ITALIA | ||||||
| NEOPREOL 2,5 mg/5 mg/g | COMBINATII (PREDNISOLONUM+NEOMICINUM) | UNGUENT | D07CA03 | W01893001 | ANTIBIOTICE S.A. - ROMANIA | ||||||
| NEORECORMON 10000 UI/0,6ml | EPOETINUM BETA | SOL. INJ. IN SERINGA PREUMPLUTA | B03XA01 | W64395001 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| NEORECORMON 10000 UI/0,6ml | EPOETINUM BETA | SOL. INJ. IN SERINGA PREUMPLUTA | B03XA01 | W64395002 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| NEORECORMON 2000 UI/0,3ml | EPOETINUM BETA | SOL. INJ. IN SERINGA PREUMPLUTA | B03XA01 | W64396001 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| NEORECORMON 2000 UI/0,3ml | EPOETINUM BETA | SOL. INJ. IN SERINGA PREUMPLUTA | B03XA01 | W64396002 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| NEORECORMON 30000 UI/0,6ml | EPOETINUM BETA | SOL. INJ. IN SERINGA PREUMPLUTA | B03XA01 | W64397001 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| NEORECORMON 30000 UI/0,6ml | EPOETINUM BETA | SOL. INJ. IN SERINGA PREUMPLUTA | B03XA01 | W64397002 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| NEORECORMON 4000 UI/0,3ml | EPOETINUM BETA | SOL. INJ. IN SERINGA PREUMPLUTA | B03XA01 | W64398001 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| NEORECORMON 4000 UI/0,3ml | EPOETINUM BETA | SOL. INJ. IN SERINGA PREUMPLUTA | B03XA01 | W64398002 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| NEORECORMON 5000 UI/0,3ml | EPOETINUM BETA | SOL. INJ. IN SERINGA PREUMPLUTA | B03XA01 | W64399001 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| NEORECORMON 5000 UI/0,3ml | EPOETINUM BETA | SOL. INJ. IN SERINGA PREUMPLUTA | B03XA01 | W64399002 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| NEOSTIGMINA LPH 15 mg | NEOSTIGMINI BROMIDUM | COMPR. | N07AA01 | W52868001 | LABORMED PHARMA S.A. - ROMANIA | ||||||
| NEOSTIGMINA LPH 15 mg | NEOSTIGMINI BROMIDUM | COMPR. | N07AA01 | W52868002 | LABORMED PHARMA S.A. - ROMANIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman